Control of biodegradation of a Mg alloy in simulated body fluid

Mg alloy AZ31 is an attractive candidate for coronary artery stents, as it possesses excellent biocompatibility in human body and good mechanical properties. However, AZ31 magnesium alloys generally have poor corrosion resistance in the body environment. This paper reports on the early stages of an investigation into the corrosion mechanism and the morphology of corrosion of AZ31 in simulated body fluid (SBF). The investigation will also consider ways of improving corrosion resistance of this alloy in SBF through the use of ionic liquids. The results to date have shown that AZ31 suffers severe localized pitting corrosion in SBF. The pits mainly develop adjacent to the Al-Mn intermetallic second phase in the α matrix. Energy Dispersive X-Ray Spectroscopy results revealed the presence of Mg, O, Ca, and P in the layer of corrosion product. Treatment of the AZ31 alloy prior to corrosion testing in SBF with the ionic liquid trimethyl (butyl) phosphonium diphenyl phosphate (P1444DPP) produced some increase in the corrosion resistance of the alloy.

[1]  D. Macfarlane,et al.  The effect of potential bias on the formation of ionic liquid generated surface films on Mg alloys , 2010 .

[2]  Shizhe Song,et al.  A Possible Biodegradable Magnesium Implant Material , 2007 .

[3]  D. Mantovani,et al.  Developments in metallic biodegradable stents. , 2010, Acta biomaterialia.

[4]  D. Macfarlane,et al.  New insights into the fundamental chemical nature of ionic liquid film formation on magnesium alloy surfaces. , 2009, ACS Applied Materials and Interfaces.

[5]  J. Gray-Munro,et al.  The mechanism of deposition of calcium phosphate coatings from solution onto magnesium alloy AZ31. , 2009, Journal of biomedical materials research. Part A.

[6]  Alexis M Pietak,et al.  Magnesium and its alloys as orthopedic biomaterials: a review. , 2006, Biomaterials.

[7]  C. Hutchinson,et al.  Corrosion of magnesium alloy ZE41 : The role of microstructural features , 2009 .

[8]  Karl-Heinz Waldmann,et al.  Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  H. Haferkamp,et al.  In vivo corrosion of four magnesium alloys and the associated bone response. , 2005, Biomaterials.

[10]  R. Virmani,et al.  Preclinical restenosis models and drug-eluting stents: still important, still much to learn. , 2004, Journal of the American College of Cardiology.

[11]  D. Macfarlane,et al.  Exploring corrosion protection of Mg via ionic liquid pretreatment , 2007 .

[12]  J. Vormann.  Magnesium: nutrition and metabolism. , 2003, Molecular aspects of medicine.

[13]  Changsong Dai,et al.  Corrosion behaviors of Mg and its alloys with different Al contents in a modified simulated body fluid , 2009 .

[14]  Raimund Erbel,et al.  Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial , 2007, The Lancet.

[15]  D. Macfarlane,et al.  Synthesis and physical property characterisation of phosphonium ionic liquids based on P(O)2(OR)2− and P(O)2(R)2− anions with potential application for corrosion mitigation of magnesium alloys , 2008 .

[16]  Stephen X. Zhang,et al.  An Investigation of a Phosphinate-Based Ionic Liquid for Corrosion Protection of Magnesium Alloy AZ31 , 2007 .

[17]  W. Zhou,et al.  Effect of heat treatment on corrosion behaviour of magnesium alloy AZ91D in simulated body fluid , 2010 .

[18]  D. Eliezer,et al.  The relation between microstructure and corrosion behavior of GTA welded AZ31B magnesium sheet , 2007 .

[19]  Fernando Alfonso,et al.  Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. , 2005, Journal of the American College of Cardiology.

[20]  G. Song,et al.  Understanding Magnesium Corrosion—A Framework for Improved Alloy Performance , 2003 .